Infant and toddler health | Infant Development, Newborn Care, Disease Prevention, & Toddler Health
Table of Contents Table of Contents Ask the Chatbot a Question infant and toddler health, area of medicine concerned with...
disease
Savara Begins Rolling BLA for Molbreevi for Rare Lung Disease
alveoli © Kenny Parker - stock.adobe.comPharmaceutical company Savara has initiated a rolling biologics license application (BLA) with the FDA for...
electronRx to launch purpleDx pulmonary disease smartphone app for remote lung function monitoring
electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx,...
FDA Approves Bimzelx for Inflammatory Skin Disease
hidradenitis suppurativa © Lea - stock.adobe.comUCB announced today that the FDA has approved Bimzelx (bimekizumab-bkzx) for the treatment of moderate-to-severe...
FDA Sets Date For Resubmitted Dupixent in Inflammatory Skin Disease
The FDA has accepted the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric...
Research aims to improve interstitial lung disease prognosis with new imaging agent
Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker...
Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease
LONDON, Sept. 10, 2024 /PRNewswire/ -- Serac Healthcare Limited ("Serac Healthcare" or "the Company"), a clinical radiopharmaceutical company developing innovative...
Chronic kidney disease and the global public health agenda: an international consensus
World Health Organization. SDG target 3.4 non-communicable diseases and mental health. (2024).World Health Organization. Non-communicable diseases. (2022).Hsu, C. Y. et...
Kalydeco slows CF disease progression over time, study finds
Treatment with Kalydeco (ivacaftor) for almost eight years consistently improved lung function and reduced mortality in people with cystic fibrosis...
